Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday broker round-up UPDATE

Tue, 29th Oct 2013 08:48

Adept Telecom: Northland Capital revises target price from 145p to 165p and reiterates a buy recommendation.Aggreko: JP Morgan reduces target price from 1620p to 1505p, while its neutral recommendation remains unchanged. UBS cuts target price from 1610p to 1555p keeping its neutral rating.APR Energy: Investec raises target price from 900p to 1150p and stays with its hold recommendation.ARM Holdings: RBC Capital moves target price from 1050p to 1080p and retains an outperform rating.Barratt Developments: Liberum Capital ups target price from 374p to 387p and maintains a buy recommendation.Bellway: Liberum Capital takes target price from 1700p to 1760p and retains its buy recommendation.Berkeley Group: Liberum Capital raises target price from 2400p to 2634p, while reiterating a hold recommendation.Blur Group: Liberum Capital raises target price from 400p to 700p and stays with its buy recommendation.Bovis Homes Group: Liberum Capital increases target price from 791p to 911p upgrading to buy.Braemer Shipping Services: Westhouse Securities takes target price from 515p to 590p and reiterates an add rating.BT Group: Bank of America ups target price from 350p to 400p retaining a buy recommendation.Coca-Cola HBC: Nomura reduces target price from 1600p to 1500p and downgrades from neutral to reduce.EMIS Group: N+1 Singer takes target price to 748p upgrading from hold to buy.Europa Oil & Gas: Northland Capital shifts target price from 17.60p to 19.70p and stays with its buy recommendation.Genel Energy: RBC Capital revises target price from 1100p to 1300p and maintains an outperform rating.Getech: WH Ireland shifts target price from 86p to 92p staying with its buy recommendation.GlaxoSmithKline: Barclays lowers target price from 1555p to 1545p and retains an equal-weight rating.Halfords Group: Investec ups target price from 400p to 460p and maintains its buy recommendation.HSBC Holdings: Goldman Sachs cuts target price from 950p to 900p, while reiterating its strong buy recommendation.ITV: Berenberg raises target price from 91p to 155p, but downgrades from hold to sell.Kirkland Lake Gold: Investec cuts target price from 377p to 353p, while its buy recommendation is kept.Lloyds Banking Group: Goldman Sachs shifts target price from 75p to 76p and maintains a neutral rating. Numis downgrades to hold with a target price of 85p.Microgen: Investec lowers target price from 147p to 143p and keeps a hold recommendation. Westhouse Securities cuts target price from 155p to 145p, while upgrading to add.Next Fifteen Communications: Canaccord Genuity reduces target price from 120p to 94p downgrading from buy to hold.Persimmon: Liberum Capital takes target price from 1245p to 1261p, while its hold recommendation remains unaltered.Playtech: Investec places its target price (prev.: 630p) under review, while staying with its hold recommendation. Canaccord Genuity raises target price from 780p to 825p retaining its buy recommendation. Daniel Stewart increases target price from 790p to 840p and keeps its buy recommendation.Redrow: Liberum Capital ups target price from 241p to 304p and upgrades to buy.Regus: Investec downgrades from buy to add with a target price of 205p.Salamander Energy: RBC Capital cuts target price from 250p to 170p downgrading to neutral.Shire: Barclays increases target price from 2515p to 2800p, while its overweight rating is kept.Stagecoach: Investec places its target price (prev.: 325p) under review, while leaving its add rating unchanged.Standard Chartered: Goldman Sachs reduces target price from 1900p to 1700p leaving its neutral rating unaltered.Taylor Wimpey: Liberum Capital moves target price from 113p to 127p and keeps a buy recommendation.
More News
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more
4 Jan 2024 14:01

UK dividends calendar - next 7 days

Friday 5 January 
British Land Co PLCdividend payment date
Hill & Smith PLCdividend payment date
JD Sports Fashion PLCdividend payment date
JPMorgan Global Growth & Income PLCdividend payment date
Liontrust Asset Management PLCdividend payment date
Lok'n Store Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
RS Group PLCdividend payment date
Tate & Lyle PLCdividend payment date
Monday 8 January 
abrdn Equity Income Trust PLCdividend payment date
Intermediate Capital Group PLCdividend payment date
Tuesday 9 January 
no events scheduled 
Wednesday 10 January 
Assura PLCdividend payment date
Bellway PLCdividend payment date
Fidelity Special Values PLCdividend payment date
LXi REIT PLCdividend payment date
Severn Trent PLCdividend payment date
Volex PLCdividend payment date
Vp PLCdividend payment date
Thursday 11 January 
AJ Bell PLCex-dividend payment date
Ashtead Group PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
CMC Markets PLCdividend payment date
dotdigital Group PLCex-dividend payment date
Ecora Resources PLCex-dividend payment date
European Assets Trust PLCex-dividend payment date
Foresight Group Holdings Ltdex-dividend payment date
GSK PLCdividend payment date
ICG-Longbow Senior Secured UK Property Debt Investments Ltdex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
Keystone Positive Change Investment Trust PLCex-dividend payment date
LondonMetric Property PLCdividend payment date
Murray International Trust PLCex-dividend payment date
National Grid PLCdividend payment date
Primary Health Properties PLCex-dividend payment date
Sage Group PLCex-dividend payment date
Smiths News PLCex-dividend payment date
SSE PLCex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
TR Property Investment Trust PLCdividend payment date
Walker Crips Group PLCex-dividend payment date
WH Smith PLCex-dividend payment date
Worldwide Healthcare Trust PLCdividend payment date
XPS Pensions Group PLCex-dividend payment date
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.